Erratum: A microfluidic chip based model for the study of full thickness human intestinal tissue using dual flow (Biomicrofluidics (2016) 10 (064101) DOI: 10.1063/1.4964813);A microfluidic chip based model for the study of full thickness human intestinal tissue using dual flow

Biomicrofluidics

Volumn 10, Issue 6, 2016, Pages

  Dawson, A ^a   Dyer, C ^a   Macfie, J ^b   Davies, J ^c   Karsai, L ^d   Greenman, J ^a   Jacobsen, M ^e,f,g  

^a UNIVERSITY OF HULL   (United Kingdom)

^b SCARBOROUGH HOSPITAL   (United Kingdom)

^c Castlehill Hospital   (United Kingdom)

^d HULL ROYAL INFIRMARY   (United Kingdom)

^e Østfold Hospital Trust   (Norway)

^f UNIVERSITY OF OSLO   (Norway)

^g NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL CULTURE; CELL CULTURE; DISEASES; FLUIDIC DEVICES; MICROFLUIDICS;

CELL CULTURE MODELS; DISEASED TISSUES; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASE; LACTATE DEHYDROGENASE; MICRO-FLUIDIC DEVICES; MICROFLUIDIC CHIP; ULCERATIVE COLITIS;

TISSUE;

EID: 84994908317     PISSN: 19321058     EISSN: None     Source Type: Journal    
DOI: 10.1063/1.5023568     Document Type: Erratum

References (39)

1. M. Z. Cader and A. Kaser, "Recent advances in inflammatory bowel disease: Mucosal immune cells in intestinal inflammation," Gut 62(11), 1653-1664 (2013). 10.1136/gutjnl-2012-303955
2. S. Danese, "New therapies for inflammatory bowel disease: From the bench to the bedside," Gut 61(6), 918-932 (2012). 10.1136/gutjnl-2011-300904
3. S. G. Nugent, D. Kumar, D. S. Rampton, and D. F. Evans, "Intestinal luminal pH in inflammatory bowel disease: Possible determinants and implications for therapy with aminosalicylates and other drugs," Gut 48(4), 571-577 (2001). 10.1136/gut.48.4.571
4. S. B. Hanauer, "Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities," Inflammatory Bowel Dis. 12(5), S3-S9 (2006). 10.1097/01.MIB.0000195385.19268.68
5. F. Shanahan, "Probiotics and inflammatory bowel disease: Is there a scientific rationale?," Inflammatory Bowel Dis. 6(2), 107-115 (2000). 10.1097/00054725-200005000-00007
6. K. Tsilingiri, T. Barbosa, G. Penna et al., "Probiotic and postbiotic activity in health and disease: Comparison on a novel polarised ex-vivo organ culture model," Gut 61(7), 1007-1015 (2012). 10.1136/gutjnl-2011-300971
7. A. N. Ananthakrishnan, S. C. Cheng, T. Cai et al., "Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases," Clin. Gastroenterol. Hepatol. 12(8), 1342-8.e1 (2014).
8. A. Boleij and H. Tjalsma, "Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer," Biol. Rev. 87(3), 701-730 (2012). 10.1111/j.1469-185X.2012.00218.x
9. S. H. Itzkowitz and D. H. Present "Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease," Inflammatory Bowel Dis. 11(3), 314-321 (2005).
10. J. K. Triantafillidis, G. Nasioulas, and P. A. Kosmidis, "Colorectal cancer and inflammatory bowel disease: Epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies," Anticancer Res. 29(7), 2727-2737 (2009).
11. B. Chassaing, J. D. Aitken, M. Malleshappa, and M. Vijay-Kumar, "Dextran sulfate sodium (DSS)-induced colitis in mice," Curr. Protoc. Immunol. 104(15.25), 15.25.1-15.25.14 (2014). 10.1002/0471142735.im1525s104
12. C. R. Kleiveland, L. T. O. Hult, S. Spetalen et al., "The noncommensal Bacterium Methylococcus capsulatus (Bath) ameliorates dextran sulfate (sodium salt)-induced ulcerative colitis by influencing mechanisms essential for maintenance of the colonic barrier function," Appl. Environ. Microbiol. 79(1), 48-56 (2013). 10.1128/AEM.02464-12
13. P. S. Dulai, C. A. Siegel, J.-F. Colombel, W. J. Sandborn, and L. Peyrin-Biroulet, "Systematic review: Monotherapy with antitumour necrosis factor a agents versus combination therapy with an immunosuppressive for IBD," Gut 63(12), 1843-1853 (2014). 10.1136/gutjnl-2014-307126
14. C. J. Bettinger and J. T. Borenstein, "Biomaterials-based microfluidics for engineered tissue constructs," Soft Matter 6(20), 4999-5015 (2010). 10.1039/c0sm00247j
15. H. J. Kim and D. E. Ingber, "Gut-on-a-chip microenvironment induces human intestinal cells to undergo villus differentiation," Integr. Biol. 5(9), 1130-1140 (2013). 10.1039/c3ib40126j
16. A. Ponder and M. D. Long, "A clinical review of recent findings in the epidemiology of inflammatory bowel disease," Clin. Epidemiol. 5, 237-247 (2013).
17. H. J. Kim, D. Huh, G. Hamilton, and D. E. Ingber, "Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow," Lab Chip 12(12), 2165-2174 (2012). 10.1039/c2lc40074j
18. L. L. Clarke, "A guide to Ussing chamber studies of mouse intestine," Am. J. Physiol. Gastrointest. Liver Physiol. 296(6), G1151-G1166 (2009). 10.1152/ajpgi.90649.2008
19. K. W. Lomasney and N. P. Hyland, "The application of Ussing chambers for determining the impact of microbes and probiotics on intestinal ion transport," Can. J. Physiol. Pharmacol. 91(9), 663-670 (2013). 10.1139/cjpp-2013-0027
20. E. Rodrigues, L. Slobbe, M. Schultz, and G. Butt, "Chronic exposure to microbial stimuli affects the development of the intestinal epithelium in human colonic enteroids," FASEB J. 29, 26-28 (2015).
21. I. Maschmeyer, A. K. Lorenz, K. Schimek et al., "A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents," Lab Chip 15(12), 2688-2699 (2015). 10.1039/C5LC00392J
22. M. Baker, "Tissue models: A living system on a chip," Nature 471(7340), 661-665 (2011). 10.1038/471661a
23. S. Hattersley, D. Sylvester, C. Dyer, N. Stafford, S. Haswell, and J. Greenman, "A microfluidic system for testing the responses of head and neck squamous cell carcinoma tissue biopsies to treatment with chemotherapy drugs," Ann. Biomed. Eng. 40(6), 1277-1288 (2012). 10.1007/s10439-011-0428-9
24. S. M. Hattersley, C. E. Dyer, J. Greenman, and S. J. Haswell, "Development of a microfluidic device for the maintenance and interrogation of viable tissue biopsies," Lab Chip 8(11), 1842-1846 (2008). 10.1039/b809345h
25. S. M. Hattersley, J. Greenman, and S. J. Haswell, "Study of ethanol induced toxicity in liver explants using microfluidic devices," Biomed. Microdevices 13(6), 1005-1014 (2011). 10.1007/s10544-011-9570-2
26. S. M. Hattersley, J. Greenman, and S. J. Haswell, "The application of microfluidic devices for viral diagnosis in developing countries," Methods Mol. Biol. 949, 285-303 (2013). 10.1007/978-1-62703-134-9_19
27. E. Cuevas, D. B. Jones, and D. H. Wright, "Immunohistochemical detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues," J. Pathol. 169(4), 477-478 (1993). 10.1002/path.1711690415
28. R. Najafi and S. M. Bernard, "Use of physiologically balanced, ionized, acidic solution in wound healing," U.S. patent US6426066 B1 (30 July 2002).
29. J. Westerhout, E. van de Steeg, D. Grossouw et al., "A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices," Eur. J. Pharm. Sci. 63, 167-177 (2014). 10.1016/j.ejps.2014.07.003
30. A. Webster, C. E. Dyer, S. J. Haswell, and J. Greenman, "A microfluidic device for tissue biopsy culture and interrogation," Anal. Methods 2(8), 1005-1007 (2010). 10.1039/c0ay00293c
31. J. Woods, P. T. Docker, C. E. Dyer, S. J. Haswell, and J. Greenman, "On-chip integrated labelling, transport and detection of tumour cells," Electrophoresis 32(22), 3188-3195 (2011). 10.1002/elps.201100172
32. M. Schaubeck, T. Clavel, J. Calasan et al., "Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence," Gut 65(2), 225-237 (2016). 10.1136/gutjnl-2015-309333
33. D. Sylvester, S. M. Hattersley, N. D. Stafford, S. J. Haswell, and J. Greenman, "Development of microfluidic-based analytical methodology for studying the effects of chemotherapy agents on cancer tissue," Current Analyt. Chem. 9(1), 2-8 (2013). 10.2174/1573411011309010002
34. D. T. Rubin, "The rationale and growth of advanced training in inflammatory bowel disease," Gastroenterology 148(4), 696-700 (2015). 10.1053/j.gastro.2015.02.036
35. S. C. Ng, C. N. Bernstein, M. H. Vatn et al., "Geographical variability and environmental risk factors in inflammatory bowel disease," Gut 62(4), 630-649 (2013). 10.1136/gutjnl-2012-303661
36. E.-M. Materne, I. Maschmeyer, A. K. Lorenz et al., "The multi-organ chip-A microfluidic platform for long-term multi-tissue coculture," J. Vis. Exp. 98, e52526 (2015). 10.3791/52526
37. A. D. van der Meer and A. van den Berg, "Organs-on-chips: breaking the in vitro impasse," Integr. Biol. 4(5), 461-470 (2012). 10.1039/c2ib00176d
38. A. Williamson, S. Singh, U. Fernekorn, and A. Schober, "The future of the patient-specific body-on-a-chip," Lab Chip 13(18), 3471-3480 (2013). 10.1039/c3lc50237f
39. P. Loskill, S. G. Marcus, A. Mathur, W. M. Reese, and K. E. Healy, "μOrgano: A Lego™ like plug & play system for modular multi-organ-chips," PLoS One 10(10), e0139587 (2015). 10.1371/journal.pone.0139587